Caladrius Bio (CLBS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | CLBS | GDTC | PLUR | ||
| Company | Caladrius Bio | Cytomed Therapeutics Limited | Pluri Inc | ||
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NASDAQ | ||
| Open | 9.7200 | 2.46 | 4.52 | ||
| High | 9.7500 | 2.58 | 4.52 | ||
| Low | 5.7300 | 2.33 | 4.33 | ||
| Last | 6.3960 | 2.58 | 4.45 | ||
| Change | -1.2585 | +0.21 | -0.13 | ||
| % Change | -16.44% | +8.86% | -2.84% | ||
| Volume | 1,796,440 | 4,300 | 4,200 | ||
| 20-Day Average Volume | 1,469,975 | 26,500 | 30,075 | ||
| Previous Close | 7.6545 | 2.37 | 4.58 | ||
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | ||
| Has Options | No | No | No | ||
| Technicals | |||||
| 20-Day Moving Average | 0.5057 | 2.60 | 4.97 | ||
| 20-Day Raw Stochastic | 16.57% | 39.84% | 16.13% | ||
| 20-Day Relative Strength | 32.97% | 52.81% | 43.85% | ||
| Weighted Alpha | -64.50 | -30.51 | -28.49 | ||
| Today's Opinion | 88% Sell | 72% Buy | 88% Sell | ||
| Previous Opinion | 88% Sell | 56% Buy | 88% Sell | ||
| Last Month's Opinion | 72% Sell | 64% Buy | 88% Sell | ||
| Performance | |||||
| 5-Days | |||||
| %Chg | -16.39% since 09/07/22 | +0.39% since 12/17/24 | -2.31% since 12/17/24 | ||
| Low | 0.3820 on 09/14/22 | 2.25 on 12/20/24 | 4.20 on 12/18/24 | ||
| High | 0.6500 on 09/14/22 | 2.68 on 12/18/24 | 4.98 on 12/20/24 | ||
| 1-Month | |||||
| %Chg | -20.63% since 08/12/22 | +14.18% since 11/22/24 | -9.18% since 11/22/24 | ||
| Low | 0.3820 on 09/14/22 | 1.95 on 11/25/24 | 4.20 on 12/18/24 | ||
| High | 0.6500 on 09/14/22 | 3.35 on 12/05/24 | 5.75 on 11/29/24 | ||
| 3-Month | |||||
| %Chg | -14.72% since 06/14/22 | +76.71% since 09/24/24 | -21.93% since 09/24/24 | ||
| Low | 0.3820 on 09/14/22 | 1.20 on 09/25/24 | 4.20 on 12/18/24 | ||
| High | 0.6500 on 09/14/22 | 3.56 on 10/23/24 | 6.18 on 09/30/24 | ||
| 6-Month | |||||
| %Chg | -34.40% since 03/14/22 | +24.64% since 06/24/24 | -10.07% since 06/24/24 | ||
| Low | 0.3820 on 09/14/22 | 1.20 on 09/25/24 | 4.20 on 12/18/24 | ||
| High | 0.7960 on 03/24/22 | 3.56 on 10/23/24 | 6.35 on 07/08/24 | ||
| Key Statistics | |||||
| Market Capitalization, $K | 25,833 | 25,928 | 25,459 | ||
| Shares Outstanding, K | 60,583 | 10,940 | 5,559 | ||
| Annual Sales | 0 | 0 | 330,000 | ||
| Annual Net Income | -27,470,000 | -3,130,000 | -20,890,000 | ||
| Last Quarter Sales | 0 | N/A | 330,000 | ||
| Last Quarter Net Income | -6,630,000 | N/A | -5,880,000 | ||
| 60-Month Beta | 0.91 | -0.14 | 1.64 | ||
| Per-Share Information | |||||
| Most Recent Earnings | -0.11 on 08/04/22 | N/A | -1.08 on 11/12/24 | ||
| Latest Earnings Date | 11/03/22 | 07/22/24 | 02/10/25 | ||
| Most Recent Dividend | N/A | N/A | N/A | ||
| Next Ex-Dividends Date | N/A | N/A | N/A | ||
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 0.00 | 0.00 | ||